CREDIT SUISSE AG/ - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AC4. A total of 19 filers reported holding CLOVIS ONCOLOGY INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q3 2021$1,823,000
-37.1%
2,500,000
-35.9%
0.00%
-50.0%
Q2 2021$2,898,000
-1.7%
3,900,0000.0%0.00%0.0%
Q1 2021$2,947,000
+6.2%
3,900,000
-2.5%
0.00%
+100.0%
Q4 2020$2,774,000
-0.9%
4,000,0000.0%0.00%
-50.0%
Q3 2020$2,800,000
+84.9%
4,000,000
+60.0%
0.00%
+100.0%
Q2 2020$1,514,000
-48.8%
2,500,000
-50.0%
0.00%
-66.7%
Q1 2020$2,955,000
-5.8%
5,000,0000.0%0.00%
+50.0%
Q4 2019$3,138,000
-21.4%
5,000,000
-47.7%
0.00%
-33.3%
Q3 2019$3,992,000
-32.8%
9,553,0000.0%0.00%
-40.0%
Q2 2019$5,943,000
-10.9%
9,553,000
+11.7%
0.01%
-16.7%
Q1 2019$6,670,000
-15.3%
8,553,000
-24.0%
0.01%
-25.0%
Q4 2018$7,875,000
-23.3%
11,253,000
-15.3%
0.01%
-11.1%
Q3 2018$10,264,000
-8.5%
13,278,000
+9.1%
0.01%
-18.2%
Q2 2018$11,212,00012,175,0000.01%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q1 2021
NameSharesValueWeighting ↓
Antara Capital LP 55,678,000$42,628,0003.59%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 30,066,000$22,875,0000.91%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 29,000,000$21,750,000,0000.31%
FARALLON CAPITAL MANAGEMENT LLC 51,910,000$39,243,0000.20%
OAKTREE CAPITAL MANAGEMENT LP 6,349,000$4,860,0000.07%
Psagot Value Holdings Ltd. 1,500,000$1,141,0000.03%
Allianz Asset Management GmbH 29,945,000$22,766,0000.02%
D. E. Shaw & Co., Inc. 25,050,000$19,155,0000.02%
AMERIPRISE FINANCIAL INC 42,200,000$31,887,0000.01%
PALISADE CAPITAL MANAGEMENT, LP 330,000$250,0000.01%
View complete list of CLOVIS ONCOLOGY INC shareholders